Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 162515
MIM: 615765
HGNC: 23093
Ensembl: ENSG00000174326
Variants:
dbSNP: 162515
ClinVar: 162515
TCGA: ENSG00000174326
COSMIC: SLC16A11
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000174326 | ENST00000308009 | Q8NCK7 |
| ENSG00000174326 | ENST00000447225 | C9JRM8 |
| ENSG00000174326 | ENST00000574600 | I3L431 |
| ENSG00000174326 | ENST00000662352 | A0A590UJX4 |
Expression (GTEx)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 35831226 | 2022 | Downregulation of SLC16A11 is Present in Offspring of Mothers with Gestational Diabetes. | 2 |
| 35831226 | 2022 | Downregulation of SLC16A11 is Present in Offspring of Mothers with Gestational Diabetes. | 2 |
| 33561739 | 2021 | The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes. | 1 |
| 33909378 | 2021 | Genetic variants in the SLC16A11 gene are associated with increased BMI and insulin levels in nondiabetic Chilean population. | 1 |
| 33561739 | 2021 | The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes. | 1 |
| 33909378 | 2021 | Genetic variants in the SLC16A11 gene are associated with increased BMI and insulin levels in nondiabetic Chilean population. | 1 |
| 30475225 | 2019 | The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes. | 11 |
| 30673611 | 2019 | Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes. | 11 |
| 30673611 | 2019 | Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes. | 11 |
| 30696834 | 2019 | Associations between SLC16A11 variants and diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). | 5 |
| 30475225 | 2019 | The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes. | 11 |
| 30673611 | 2019 | Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes. | 11 |
| 30673611 | 2019 | Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes. | 11 |
| 30696834 | 2019 | Associations between SLC16A11 variants and diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). | 5 |
| 28101933 | 2017 | Associations of common variants in the SLC16A11, TCF7L2, and ABCA1 genes with pediatric-onset type 2 diabetes and related glycemic traits in families: A case-control and case-parent trio study. | 15 |
Citation
Dessen P
SLC16A11 (solute carrier family 16 member 11)
Atlas Genet Cytogenet Oncol Haematol. 2014-11-01
Online version: http://atlasgeneticsoncology.org/gene/73289/slc16a11-(solute-carrier-family-16-member-11)
